Cleveland Clinic Lerner Research Institute Logo
Cleveland Clinic Lerner Research Institute Logo
  • About
  • Science
    • Laboratories
    • Clinical & Translational Research
    • Departments
      Biomedical Engineering Cancer Biology Cardiovascular & Metabolic Sciences Florida Research & Innovation Center Genomic Medicine Immunotherapy & Precision Immuno-Oncology
      Infection Biology Inflammation & Immunity Neurosciences Ophthalmic Research Quantitative Health Sciences Translational Hematology & Oncology Research
    • Centers & Programs
      Advanced Musculoskeletal Imaging Angiogenesis Center Cardiovascular Diagnostics & Prevention Computational Life Sciences Consortium for Pain Genitourinary Malignancies Research
      Microbiome & Human Health Musculoskeletal Research Northern Ohio Alcohol Center Pathogen & Human Health Research Populations Health Research Therapeutics Discovery
  • Core Services
    • Ohio
      3D Printing BioRobotics & Mechanical Testing Cell Culture Cleveland Clinic BioRepository Computational Immunology Platform Computing Services Discovery Lab Electron Microscopy Electronics Engineering Flow Cytometry
      Genomic Medicine Institute Biorepository Genomics Glassware Histology Hybridoma Immunohistochemistry Immunomonitoring Lab Instrument Refurbishing & Repair Laboratory Diagnostic Lerner Research Institute BioRepository
      Light MicroscopyMechanical Prototyping Microbial Culturing & Engineering Microbial Sequencing & Analytics Resources Media Preparation Molecular Biotechnology Nitinol Polymer Proteomics & Metabolomics Therapeutics Discovery
    • Florida
      Bioinformatics
      Flow Cytometry
      Imaging
  • Education & Training
    • Graduate Programs Molecular Medicine PhD Program Postdoctoral Program
      Research Intensive Summer Experience (RISE) Undergraduate & High School Programs
  • News
  • Careers
    • Faculty Positions Research Associate & Project Staff Postdoctoral Positions
      Technical & Administrative
  • Donate
  • Contact
  • About
  • Science
    • Scientific Programs
    • Laboratories
    • Clinical & Translational Research
    • Departments
      Biomedical Engineering Cancer Biology Cardiovascular & Metabolic Sciences Florida Research & Innovation Center Genomic Medicine Immunotherapy & Precision Immuno-Oncology
      Infection Biology Inflammation & Immunity Neurosciences Ophthalmic Research Quantitative Health Sciences Translational Hematology & Oncology Research
    • Centers & Programs
      Advanced Musculoskeletal Imaging Angiogenesis Center Cardiovascular Diagnostics & Prevention Computational Life Sciences Consortium for Pain Genitourinary Malignancies Research
      Microbiome & Human Health Musculoskeletal Research Northern Ohio Alcohol Center Pathogen & Human Health Research Populations Health Research Therapeutics Discovery
  • Core Services
    • All Cores
    • Ohio
      3D Printing BioRobotics & Mechanical Testing Cell Culture Cleveland Clinic BioRepository Computational Immunology Platform Computing Services Discovery Lab Electron Microscopy Electronics Engineering Flow Cytometry
      Genomic Medicine Institute BiorepositoryGenomics Glassware Histology Hybridoma Immunohistochemistry Immunomonitoring Lab Instrument Refurbishing & Repair Laboratory Diagnostic Lerner Research Institute BioRepository
      Light MicroscopyMechanical Prototyping Microbial Culturing & Engineering Microbial Sequencing & Analytics Resources Media Preparation Molecular Biotechnology Nitinol Polymer Proteomics & Metabolomics Therapeutics Discovery
    • Florida
      Bioinformatics
      Flow Cytometry
      Imaging
  • Education & Training
    • Research Education & Training Center
    • Graduate Programs Molecular Medicine PhD Program Postdoctoral Program
      Research Intensive Summer Experience (RISE) Undergraduate & High School Programs
  • News
  • Careers
    • Faculty Positions Research Associate & Project Staff Postdoctoral Positions
      Technical & Administrative
  • Donate
  • Contact
  • Search

George Stark Laboratory

❮Cancer Biology George Stark Laboratory
  • George Stark Laboratory
  • Principal Investigator
  • Research
  • Our Team
  • Publications
  • Research News

Principal Investigator

George Stark Headshot

George Stark, PhD

Staff
Email: starkg@ccf.org
Location: Cleveland Clinic Main Campus

Research

Our cells are instructed on how to behave by a large number of external signals, which come from contact with neighboring cells, from signaling molecules that enter the circulation from elsewhere in the body to affect distant cells, and from signaling molecules that alert us to the presence of invading organisms (viruses, bacteria, fungi, parasites). The signals are conveyed from the outside of the cell to the inside by specialized receptors on the cell surface.  Responses to signals result in changes in cellular functions, for example, by increasing the level of antiviral proteins in response to an infection. These changes are carried out by increasing the amounts of specific proteins or by changing their properties.  We study the details of these complex interactions in innate immunity and in cancer.


Biography


Education & Professional Highlights

Research

Research

Insertional mutagenesis: We use a lentiviral vector to insert a strong promoter in or near genes in human cells, generating populations of millions of cells, each of which can over-express a different specific protein. We then enrich the population for cells with a specific phenotype of interest, for example, resistance to a drug.  Sequencing the RNAs that are linked to vector sequences gives us candidate genes whose products may mediate the phenotype.  This methodology has very broad applications. We have used it identify novel methylations of STAT3 that modulate function and to identify mechanisms of resistance to ionizing radiation.  We also collaborate enthusiastically with other labs who wish to use this method.  

Responses to interferon (IFN):  The response to type I IFNs is modulated by a growing number of secondary mechanisms, some of which have profound effects on the roles of IFN in tumorigenesis and resistance to infections. Tyrosine phosphorylation of STAT1 and STAT2 are vital fo the primary transcriptional response to IFN, but we now know that phosphorylation of two threonine residues of STAT2 have major regulatory effects.  Furthermore, without tyrosine phosphorylation, STAT2 has important roles in driving gene expression, including genes whose products mediate drug resistance in cancer.

Interferon synthesis in cancer:  Cancer cells make endogenous Type I IFN in response to internal signals, especially dsRNA produced from endogenous retroviral elements in the DNA and cytoplasmic DNA, produced in response to intrinsic DNA damage, which activates the cGAS/STING pathway, leading to IFN synthesis.  In response to endogenous IFN, cancer cells upregulate resistance to DNA damaging agents.

Cell-intrinsic roles of PD-L1: A new interest in the lab concerns the ability of PD-L1 to modulate how cells respond to IFN-1.  This aspect is separate from the well-studied PD-1/PD-L1 interaction.

Novel therapies: We are studying the new drug CBL0137 in lung cancer and are collaborating with other labs to evaluate it in preclinical models of rectal cancer and in combination with other modalities, including cis-platin and ionizing radiation.  We are also studying the anti-osteoporosis drug bazadoxifene, which inhibits STAT3 activation, as a potential therapeutic agent in GBM.

 

Our Team

Our Team

Publications

Selected Publications

IRF9 and unphosphorylated STAT2 cooperate with NF-κB to drive IL6 expression.Nan J, Wang Y, Yang J, Stark GR.Proc Natl Acad Sci U S A. 2018 Apr 10;115(15):3906-3911. doi: 10.1073/pnas.1714102115. PMID: 29581268 

The FACT inhibitor CBL0137 Synergizes with Cisplatin in Small-Cell Lung Cancer by Increasing NOTCH1Expression and Targeting Tumor-Initiating Cells.De S, Lindner DJ, Coleman CJ, Wildey G, Dowlati A, Stark GR.Cancer Res. 2018 May 1;78(9):2396-2406. doi: 10.1158/0008-5472.CAN-17-1920. PMID: 29440145

Responses to Cytokines and Interferons that Depend upon JAKs and STATs.Stark GR, Cheon H, Wang Y.Cold Spring Harb Perspect Biol. 2018 Jan 2;10(1). pii: a028555. doi: 10.1101/cshperspect.a028555. Review.PMID: 28620095

Negative regulation of type I IFN signaling by phosphorylation of STAT2 on T387.Wang Y, Nan J, Willard B, Wang X, Yang J, Stark GR. EMBO J. 2017 Jan 17;36(2):202-212. doi: 10.15252/embj.201694834. PMID: 27852626

IFNβ-dependent increases in STAT1, STAT2, and IRF9 mediate resistance to viruses and DNA damage.Cheon H, Holvey-Bates EG, Schoggins JW, Forster S, Hertzog P, Imanaka N, Rice CM, Jackson MW, Junk DJ, Stark GR.EMBO J. 2013 Oct 16;32(20):2751-63. doi: 10.1038/emboj.2013.203. PMID:24065129

Research News

Research News

...
Cleveland Clinic receives $12 million to investigate how inflammatory cytokines affect cancer progression

A new program funded by a National Cancer Institute grant aims to advance treatments that target the mechanisms tumors use to grow and survive.



...
Dr. George Stark Awarded Prestigious Steven C. Beering Award



...
Promising New Combination Drug Therapy Treats Several Models of Lethal Lung Cancer



About Lerner

About Us Careers Contact Us Donate People Directory

Science

Clinical & Translational Research Core Services Departments, Centers & Programs Laboratories Research News

Education & Training

Graduate Programs Molecular Medicine PhD Program Postdoctoral Program RISE Program Undergraduate & High School Programs

Site Information & Policies

Search Site Site Map Privacy Policy Social Media Policy

9500 Euclid Avenue, Cleveland, Ohio 44195 | © 2023 Lerner Research Institute